Novateor Resear.

Has Novateor Resear. declared dividend?

No Dividend History Available

When is the next results date for Novateor Resear.?

No Upcoming Board Meetings

Is Novateor Resear. overvalued or undervalued?

As of May 19, 2025, Novateor Research is rated as risky and overvalued, with a PE Ratio of 27.80, negative ROCE of -4.59%, and ROE of 0.38%, despite outperforming the Sensex with an 18.9% return over the past year.

As of 19 May 2025, the valuation grade for Novateor Research has moved from does not qualify to risky, indicating a significant shift in its perceived investment quality. The company is currently deemed overvalued. Key ratios include a PE Ratio of 27.80, a Price to Book Value of 3.51, and an EV to Sales ratio of 23.81, which suggest that the stock is priced high relative to its earnings and book value.<BR><BR>In comparison to its peers, Novateor Research's PE Ratio stands in stark contrast to Max Healthcare Institute Ltd., which has a PE of 100.29, and Apollo Hospitals Enterprise Ltd., with a PE of 69.03, both categorized as very expensive. This highlights the relative valuation concerns for Novateor Research, especially given its negative ROCE of -4.59% and ROE of 0.38%. While Novateor has outperformed the Sensex over the past year with a return of 18.9% compared to the Sensex's 7.55%, the underlying financial metrics suggest caution for potential investors.

What is the technical trend for Novateor Resear.?

As of May 15, 2025, Novateor Research's technical trend is neutral, with no clear bullish or bearish indicators, as the stock price remains unchanged at 57.50 despite strong long-term performance relative to the Sensex.

As of 15 May 2025, the technical trend for Novateor Resear has changed from mildly bearish to does not qualify. Given the lack of specific technical indicators such as MACD, RSI, or moving averages, and the current price remaining unchanged at 57.50, there is insufficient data to form a definitive bullish or bearish stance. The stock's performance relative to the Sensex shows strong returns over the longer term, but current technical analysis does not provide a clear direction.

Who are the peers of the Novateor Resear.?

Novateor Resear.'s peers include Indong Tea Co, Hipolin, Sinnar Bidi Udy., KMG Milk Food, Paramount Cosmet, Tasty Dairy, BKV Industries, and Shanthala FMCG. Most peers exhibit below-average management risk, growth, and capital structure, with KMG Milk Food showing the highest 1-year return at 44.01% and Novateor Resear. at 4.91%.

Peers: The peers of Novateor Resear. are Indong Tea Co, Hipolin, Sinnar Bidi Udy., KMG Milk Food, Paramount Cosmet, Tasty Dairy, BKV Industries, and Shanthala FMCG.<BR><BR>Quality Snapshot: Below Average management risk is observed at Indong Tea Co, Hipolin, Sinnar Bidi Udy., Paramount Cosmet, Tasty Dairy, Shanthala FMCG, and Novateor Resear., while KMG Milk Food and BKV Industries do not qualify. Below Average growth is found at Indong Tea Co, Hipolin, Sinnar Bidi Udy., Paramount Cosmet, Shanthala FMCG, and Novateor Resear., while Tasty Dairy has Average growth and KMG Milk Food and BKV Industries do not qualify. Below Average capital structure is noted for Indong Tea Co, Hipolin, Sinnar Bidi Udy., Paramount Cosmet, Tasty Dairy, Shanthala FMCG, and Novateor Resear., with KMG Milk Food and BKV Industries not qualifying.<BR><BR>Return Snapshot: The peer with the highest 1-year return is KMG Milk Food at 44.01%, while the lowest is Indong Tea Co at -44.29%. Novateor Resear. has a 1-year return of 4.91%, which is higher than Indong Tea Co but lower than KMG Milk Food. Additionally, the six-month return is negative for Indong Tea Co, Hipolin, Paramount Cosmet, and Shanthala FMCG.

Who are in the management team of Novateor Resear.?

As of March 2020, the management team of Novateor Resear includes Navdeep Subhashbhai Mehta (Managing Director & CFO), Tejal Navdeep Mehta (Whole-time Director), and four independent directors: Anand Rajendra Shah, Chintan Pankaj Shah, Sindhav Vipulbhai, and Jitin Jaysukh Doshi (Non-Executive Director). This diverse team guides the company's governance and strategy.

As of March 2020, the management team of Novateor Resear includes the following individuals:<BR><BR>1. Navdeep Subhashbhai Mehta - Managing Director & CFO<BR>2. Tejal Navdeep Mehta - Whole-time Director<BR>3. Anand Rajendra Shah - Independent Director<BR>4. Chintan Pankaj Shah - Independent Director<BR>5. Sindhav Vipulbhai - Independent Director<BR>6. Jitin Jaysukh Doshi - Non Executive Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and strategic direction of the company.

What does Novateor Resear. do?

Novateor Research Laboratories Ltd is a micro-cap company in the FMCG industry, incorporated in 2011 and converted to a public company in 2019. As of March 2020, it reported net sales of 1 Cr and a market cap of INR 25 Cr, with a P/E ratio of 24.00.

Overview:<BR>Novateor Research Laboratories Ltd operates in the Fast-Moving Consumer Goods (FMCG) industry and is categorized as a micro-cap company.<BR><BR>History:<BR>The company was originally incorporated as Novateor Research Laboratories Private Limited in 2011 and later converted to a Public Limited Company with its name changed to Novateor Research Laboratories Limited on April 22, 2019. The latest quarterly results reported net sales and net profit for the period ending March 2020.<BR><BR>Financial Snapshot:<BR>- Net Sales: 1 Cr (Quarterly Results - Mar 2020)<BR>- Net Profit: 0 Cr (Quarterly Results - Mar 2020)<BR>- Market-cap: INR 25 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 24.00<BR>- Industry P/E: 81<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.13<BR>- Return on Equity: 1.01%<BR>- Price to Book: 3.17<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the top shareholders of the Novateor Resear.?

The top shareholders of Novateor Resear include Navdeep Subhashbhai Mehta with 29.56%, individual investors with 26.45%, and public shareholder Jitin Jaysukhlal Doshi at 3.85%. There are currently no mutual funds or foreign institutional investors holding shares in the company.

The top shareholders of Novateor Resear include the promoters, with Navdeep Subhashbhai Mehta holding the largest stake at 29.56%. Individual investors collectively own 26.45% of the company. The highest public shareholder is Jitin Jaysukhlal Doshi, who holds 3.85%. Notably, there are no mutual funds or foreign institutional investors currently holding shares in the company.

How big is Novateor Resear.?

As of 21st July, Novateor Research Laboratories Ltd has a market capitalization of 24.00 Cr and reported Net Sales of 0.13 Cr with a Net Profit loss of 0.02 Cr for the latest quarter ending March 2020. As of March 2024, Shareholder's Funds are 8.76 Cr and Total Assets are 10.46 Cr.

As of 21st July, <BR><BR>Market Cap: Novateor Research Laboratories Ltd has a market capitalization of 24.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest quarter ending March 2020, the company reported Net Sales of 0.13 Cr and a Net Profit loss of 0.02 Cr.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2024, with Shareholder's Funds amounting to 8.76 Cr and Total Assets of 10.46 Cr.

Why is Novateor Research Laboratories Ltd falling/rising?

As of 19-May, Novateor Research Laboratories Ltd's stock price is stable at 32.85, but it has increased by 5.25% over the past month and 36.88% year-to-date, significantly outperforming the Sensex. Despite a 42.87% decline over the past year, recent positive trends and increased investor interest suggest a favorable outlook.

As of 19-May, Novateor Research Laboratories Ltd's stock price remains unchanged at 32.85, with a change of 0.00 (0.00%). Despite this stability in the current price, the stock has shown a positive trend over the past month, increasing by 5.25%, while the benchmark Sensex has declined by 4.19%. Year-to-date, the stock has risen significantly by 36.88%, contrasting with the Sensex's drop of 11.76%. <BR><BR>In the longer term, the stock has demonstrated impressive growth over the past five years, with a staggering increase of 329.41%, compared to the Sensex's 50.70% rise. However, it is important to note that over the past year, the stock has decreased by 42.87%, while the Sensex has only fallen by 8.36%. <BR><BR>Today's performance indicates that Novateor Research Laboratories Ltd has outperformed its sector by 2.46%. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 900% against the five-day average, suggesting heightened interest in the stock. <BR><BR>While the stock's current price is stable, the overall positive trends in recent performance and increased investor activity may contribute to a favorable outlook for the stock moving forward.

Which are the latest news on Novateor Resear.?